abrdn plc Acquires New Holdings in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)

abrdn plc acquired a new stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 552,572 shares of the biopharmaceutical company’s stock, valued at approximately $6,006,000. abrdn plc owned approximately 1.01% of Marinus Pharmaceuticals as of its most […]

Leave a Reply

Your email address will not be published.

Previous post Impinj (NASDAQ:PI) PT Raised to $156.00 at The Goldman Sachs Group
Next post Xponance Inc. Acquires Shares of 725 Enstar Group Limited (NASDAQ:ESGR)